Related references
Note: Only part of the references are listed.Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults
Beth D. Kirkpatrick et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America
Luis Villar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The dengue vaccine pipeline: Implications for the future of dengue control
Lauren M. Schwartz et al.
VACCINE (2015)
The Human CD8(+) T Cell Responses Induced by a Live Attenuated Tetravalent Dengue Vaccine Are Directed against Highly Conserved Epitopes
Daniela Weiskopf et al.
JOURNAL OF VIROLOGY (2015)
Lineage II of Southeast Asian/American DENV-2 Is Associated with a Severe Dengue Outbreak in the Peruvian Amazon
Maya Williams et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2014)
Increased Replicative Fitness of a Dengue Virus 2 Clade in Native Mosquitoes: Potential Contribution to a Clade Replacement Event in Nicaragua
Claire A. Quiner et al.
JOURNAL OF VIROLOGY (2014)
Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
Maria Rosario Capeding et al.
LANCET (2014)
Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study
Jorge E. Osorio et al.
LANCET INFECTIOUS DISEASES (2014)
Evaluation of Dengue Virus strains for human challenge studies
M. P. Mammen et al.
VACCINE (2014)
Investigating the efficacy of monovalent and tetravalent dengue vaccine formulations against DENV-4 challenge in AG129 mice
Jeremy Fuchs et al.
VACCINE (2014)
Potential opportunities and perils of imperfect dengue vaccines
Isabel Rodriguez-Barraquer et al.
VACCINE (2014)
Epidemiological Trends of Dengue Disease in Thailand (2000-2011): A Systematic Literature Review
Kriengsak Limkittikul et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Recent Epidemiological Trends of Dengue in the French Territories of the Americas (2000-2012): A Systematic Literature Review
Maina L'Azou et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Epidemiology of Dengue Disease in the Philippines (2000-2011): A Systematic Literature Review
Lulu Bravo et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Epidemiological Trends of Dengue Disease in Mexico (2000-2011): A Systematic Literature Search and Analysis
Hector Gomez Dantes et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Epidemiology of Dengue Disease in Malaysia (2000-2012): A Systematic Literature Review
Abdul Hamid Mohd-Zaki et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Dengue Virus Neutralizing Antibody Levels Associated with Protection from Infection in Thai Cluster Studies
Darunee Buddhari et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
A rapid immunization strategy with a live-attenuated tetravalent dengue vaccine elicits protective neutralizing antibody responses in non-human primates
Yuping Ambuel et al.
FRONTIERS IN IMMUNOLOGY (2014)
Human immune responses to dengue virus infection: lessons learned from prospective cohort studies
Timothy P. Endy
FRONTIERS IN IMMUNOLOGY (2014)
T-cell immunity to infection with dengue virus in humans
Daniela Weiskopf et al.
FRONTIERS IN IMMUNOLOGY (2014)
Experimental Dengue Virus Challenge of Human Subjects Previously Vaccinated With Live Attenuated Tetravalent Dengue Vaccines
Wellington Sun et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
A Single Dose of Any of Four Different Live Attenuated Tetravalent Dengue Vaccines Is Safe and Immunogenic in Flavivirus-naive Adults: A Randomized, Double-blind Clinical Trial
Anna P. Durbin et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
The global distribution and burden of dengue
Samir Bhatt et al.
NATURE (2013)
Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells
Daniela Weiskopf et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Host and viral features of human dengue cases shape the population of infected and infectious Aedes aegypti mosquitoes
Nguyet Minh Nguyen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Identifying protective dengue vaccines: Guide to mastering an empirical process
Scott B. Halstead
VACCINE (2013)
Targeting the Non-structural Protein 1 from Dengue Virus to a Dendritic Cell Population Confers Protective Immunity to Lethal Virus Challenge
Hugo R. Henriques et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
Epidemiological Trends of Dengue Disease in Brazil (2000-2010): A Systematic Literature Search and Analysis
Maria Gloria Teixeira et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
Genetic and Phenotypic Characterization of Manufacturing Seeds for a Tetravalent Dengue Vaccine (DENVax)
Claire Y. -H. Huang et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
Arunee Sabchareon et al.
LANCET (2012)
CURRENT CONCEPTS Dengue
Cameron P. Simmons et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Transmission Dynamics of the Four Dengue Serotypes in Southern Vietnam and the Potential Impact of Vaccination
Laurent Coudeville et al.
PLOS ONE (2012)
Immunogenicity and efficacy of chimeric dengue vaccine (DENVax) formulations in interferon-deficient AG129 mice
Joseph N. Brewoo et al.
VACCINE (2012)
Controlling Dengue with Vaccines in Thailand
Dennis L. Chao et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Efficacy of a Tetravalent Chimeric Dengue Vaccine (DENVax) in Cynomolgus Macaques
Jorge E. Osorio et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2011)
Priming Effect of Dengue and Yellow Fever Vaccination on the Immunogenicity, Infectivity, and Safety of a Tetravalent Dengue Vaccine in Humans
Ming Qiao et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2011)
Development of DENVax: A chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever
Jorge E. Osorio et al.
VACCINE (2011)
The development of recombinant subunit envelope-based against dengue virus induced disease
Beth-Ann G. Coller et al.
VACCINE (2011)
From research to phase III: Preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine
Bruno Guy et al.
VACCINE (2011)
Replication of the Primary Dog Kidney-53 Dengue 2 Virus Vaccine Candidate in Aedes aegypti Is Modulated by a Mutation in the 5′ Untranslated Region and Amino Acid Substitutions in Nonstructural Proteins 1 and 3
Aaron C. Brault et al.
VECTOR-BORNE AND ZOONOTIC DISEASES (2011)
Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes
Scott B. Halstead et al.
LANCET INFECTIOUS DISEASES (2010)
Dengue: a continuing global threat
Maria G. Guzman et al.
NATURE REVIEWS MICROBIOLOGY (2010)
Serotype-Specific Differences in the Risk of Dengue Hemorrhagic Fever: An Analysis of Data Collected in Bangkok, Thailand from 1994 to 2006
Jessica R. Fried et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Emergence of the Asian 1 Genotype of Dengue Virus Serotype 2 in Viet Nam: In Vivo Fitness Advantage and Lineage Replacement in South-East Asia
Vu Thi Ty Hang et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects
Bruno Guy et al.
VACCINE (2008)
Antibody to dengue 1 detected more than 6 years after infection
Allison Imrie et al.
VIRAL IMMUNOLOGY (2007)
Neutralizing antibodies after infection with dengue 1 virus
Maria G. Guzman et al.
EMERGING INFECTIOUS DISEASES (2007)
Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax™-DEN2) vaccine:: Phase I clinical trial for safety and immunogenicity
Farshad Guirakhoo et al.
HUMAN VACCINES (2006)
Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, Whereas T- and B-cell-dependent immunity are less critical
S Shresta et al.
JOURNAL OF VIROLOGY (2004)
Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development
CYH Huang et al.
JOURNAL OF VIROLOGY (2003)
Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5′ noncoding region and nonstructural proteins 1 and 3
S Butrapet et al.
JOURNAL OF VIROLOGY (2000)
Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity
DW Vaughn et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Share Paper
